Cargando…

Manifesto on the overuse of SABA in the management of asthma: new approaches and new strategies

The risks of overusing short-acting β(2)-agonists (SABA), including an increase in asthma-related deaths, are many and well known. The Global Initiative on Asthma (GINA) 2019 and 2020 updates recommend as-needed inhaled corticosteroid (ICS)/formoterol as the preferred rescue medication in mild asthm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Canonica, Giorgio Walter, Paggiaro, Pierluigi, Blasi, Francesco, Musarra, Antonino, Richeldi, Luca, Rossi, Andrea, Papi, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488406/ https://www.ncbi.nlm.nih.gov/pubmed/34587829 http://dx.doi.org/10.1177/17534666211042534

Ejemplares similares

Treatment strategies for asthma: reshaping the concept of asthma management
por: Papi, Alberto, et al.
Publicado: (2020)

Defining type 2 asthma and patients eligible for dupilumab in Italy: a biomarker-based analysis
por: Canonica, Giorgio Walter, et al.
Publicado: (2021)

SABA Overuse in Russia – Burden and Possible Causes: An Analysis of the Russian Population in the SABINA III (SABA use IN Asthma) Study
por: Avdeev, Sergey, et al.
Publicado: (2022)

Overcoming Barriers to the Effective Management of Severe Asthma in Italy
por: Paggiaro, Pierluigi, et al.
Publicado: (2021)

Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany
por: Worth, Heinrich, et al.
Publicado: (2021)

Patient and physician perspectives on biological treatment in severe asthma: a Severe Asthma Network Italy survey
por: Crimi, Claudia, et al.
Publicado: (2023)

Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry
por: Puggioni, Francesca, et al.
Publicado: (2020)

Clarifying SABA overuse: Translating Canadian Thoracic Society guidelines into clinical practice
por: Ellis, Anne K., et al.
Publicado: (2022)

Clinical Consequences of the Overuse of Short-Acting β2-Adrenergic Agonists (SABA) in the Treatment of Asthma in Spain: The SABINA Study
por: Molina, Jesús, et al.
Publicado: (2023)

Targeted therapy in severe asthma today: focus on immunoglobulin E
por: Pelaia, Girolamo, et al.
Publicado: (2017)

Overuse of Short-Acting Beta-2 Agonists (SABAs) in Elite Athletes: Hypotheses to Explain It
por: Vertadier, Nicolas, et al.
Publicado: (2022)

Sex Differences in Severe Asthma: Results From Severe Asthma Network in Italy-SANI
por: Senna, Gianenrico, et al.
Publicado: (2020)

A new manifesto for the CDC
por: The Lancet
Publicado: (2009)

Asthma and COVID-19: In Defense of Evidence-Based SABA
por: Amirav, Israel, et al.
Publicado: (2020)

Step-down from high dose fixed combination therapy in asthma patients: a randomized controlled trial
por: Papi, Alberto, et al.
Publicado: (2012)

Allergen immunotherapy in asthma; what is new?
por: Passalacqua, Giovanni, et al.
Publicado: (2015)

Effective Asthma Management: Is It Time to Let the AIR out of SABA?
por: Kaplan, Alan, et al.
Publicado: (2020)

The Changing Asthma Management Landscape and Need for Appropriate SABA Prescription
por: Domingo, Christian, et al.
Publicado: (2023)

SABAs as Reliever Medications in Asthma Management: Evidence-Based Science
por: Amirav, Israel, et al.
Publicado: (2023)

Strategy for sustainability: a business manifesto
por: Werbach, Adam
Publicado: (2009)

The Hidden Burden of Severe Asthma: From Patient Perspective to New Opportunities for Clinicians
por: Scichilone, Nicola, et al.
Publicado: (2020)

SANI-Severe Asthma Network in Italy: a way forward to monitor severe asthma
por: Senna, G., et al.
Publicado: (2017)

Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center
por: Solidoro, Paolo, et al.
Publicado: (2022)

Asthma research and practice: a new journey begins
por: Celedon, Juan C., et al.
Publicado: (2015)

Severe asthma: One disease and multiple definitions
por: Bagnasco, Diego, et al.
Publicado: (2021)

Reducing Tolerance for SABA and OCS towards the Extreme Ends of Asthma Severity
por: Bakakos, Petros, et al.
Publicado: (2022)

Comparison of the Asthma Control Questionnaire and patient diaries in uncontrolled asthma
por: Singh, Dave, et al.
Publicado: (2023)

Manifesto of transdisciplinarity
por: Nicolescu, Basarab
Publicado: (2002)

The Columnist Manifesto
por: Petsko, Gregory A
Publicado: (2011)

THE CHECKLIST MANIFESTO
por: Clarke, James
Publicado: (2011)

The Mind Manifesto
Publicado: (1971)

Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry
por: Canonica, Giorgio Walter, et al.
Publicado: (2019)

High Use of SABAs is Associated with Higher Exacerbation Rate in Dutch Patients with Asthma
por: Baron, Anna Jetske, et al.
Publicado: (2021)

Safety of SABA Monotherapy in Asthma Management: a Systematic Review and Meta-analysis
por: Sriprasart, Thitiwat, et al.
Publicado: (2022)

Psychometric properties of the Spanish SABA Reliance Questionnaire (SRQ) among patients with asthma
por: Martínez, Mar, et al.
Publicado: (2023)

Manifesto on the Value of Adult Immunization: “We Know, We Intend, We Advocate”
por: Antonelli-Incalzi, Raffaele, et al.
Publicado: (2021)

Six Drivers to Face the XXI Century Challenges and Build the New Healthcare System: “La Salute in Movimento” Manifesto
por: Blasi, Francesco, et al.
Publicado: (2022)

La reina de Saba
por: Mardrus, Joseph Charles, 1868-1949
Publicado: (1992)

The Latest Manifesto on Alcohol
Publicado: (1907)

An Anti-Vivisection Manifesto
por: Trist, Sidney
Publicado: (1909)

Cannot write session to /tmp/vufind_sessions/sess_rm5gq8bjpogr6f4b699m284h2g